Crispr Therapeutics AG
CRSP
NASDAQ. Currency in USD
44.06 -2.35 ( -5.06% )
Free financials are limited to the past 5 years. With Premium you can see +30 years of financial data. Upgrade now to premium for only $2.99!
Date | 2021 | 2020 | 2019 | 2018 |
Assets | 2.75B | 1.83B | 1.07B | 489.02M |
Current Assets | 2.42B | 1.72B | 987.55M | 466.39M |
Cash and Cash Equivalents | 923.03M | 1.17B | 943.77M | 456.65M |
Cash And Short Term Investments | 2.38B | 1.69B | 943.77M | 456.65M |
Inventory | - | - | - | - |
Current Net Receivables | 305,000 | 144,000 | 99,000 | 88,000 |
Non Current Assets | 334.36M | 111.35M | 79.20M | 22.62M |
Property Plant and Equipment | 137.57M | 42.16M | 72.83M | 18.50M |
Accumulated Depreciation and Amortization | 37.81M | 21.18M | 12.05M | 7.38M |
Intangible Assets | 125,000 | 180,000 | 235,000 | 289,000 |
Intangible Assets Excluding Goodwill | 125,000 | 180,000 | 235,000 | 289,000 |
Goodwill | - | - | - | - |
Investments | 2.40B | 1.66B | 939.42M | 392.19M |
Long Term Investments | 0 | - | - | - |
Short Term Investments | 1.46B | 521.71M | 0 | - |
Other Current Assets | 38.08M | 26.14M | 43.68M | 9.66M |
Other Non Current Assets | 22.20M | 18.32M | 6.37M | 3.83M |
Other Non Current Assets | 22.20M | 18.32M | 6.37M | 3.83M |
Liabilities | 352.42M | 163.73M | 127.33M | 96.82M |
Current Liabilities | 119.88M | 94.26M | 57.11M | 27.75M |
Current Accounts Payable | 14.82M | 9.09M | 5.94M | 5.07M |
Deferred Revenue | 25.63M | 1.90M | 0 | 57.88M |
Current Debt | - | - | 8.49M | - |
Short Term Debt | 12.16M | 11.36M | 8.49M | - |
Non Current Liabilities | 232.53M | 69.47M | 70.22M | 69.08M |
Capital Lease Obligations | 225.03M | 61.43M | 52.54M | - |
Long Term Debt | - | - | - | - |
Current Long Term Debt | - | - | - | - |
Non Current Long Term Debt | - | - | - | - |
Other Current Liabilities | 91.17M | 60.99M | 41.13M | 22.27M |
Other Non Current Liabilities | 232.53M | 69.47M | 14.39M | 243,000 |
Equity | 2.40B | 1.66B | 939.42M | 392.19M |
Treasury Stock | -63,000 | -63,000 | -63,000 | -57,000 |
Retained Earnings | -195.91M | -573.58M | -224.71M | -291.57M |
Shares Outstanding | 65.95M | 65.95M | 56.93M | 47.96M |
Net Income | 377.66M | -348.87M | 66.86M | -164.98M |